Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 4 years ago

Possible Interaction: Glucose and Remogliflozin Etabonate

Research Papers that Mention the Interaction

RE reduced incremental adjusted weighted mean glucose (0–4 h) values by 42–49 mg/dL and mean glucose (0–10 h) by 52–69 mg/dL. CONCLUSIONS RE can be safely administered with insulin in type 1 diabetes and reduces plasma glucose concentrations compared with placebo.
RE significantly increased urine glucose excretion and reduced the rise in plasma glucose concentration after oral glucose.
Diabetes Care  •  2012  |  View Paper